polyclonal anti-RcPA IgG (NEXTherapeutics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namepolyclonal anti-RcPA IgG (NEXTherapeutics)
Drug Alias Nameanthrax therapy (NEXTherapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNextherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNextherapeutics
Active IndicationsN/A
Inactive IndicationsAnthrax

Other Information

ATC CodeN/A
Related LinksN/A